SCOTUS won’t resuscitate Amarin’s Vascepa patents

22-06-2021

Muireann Bolger

SCOTUS won’t resuscitate Amarin’s Vascepa patents

Pavel Kapysh / Shutterstock.com

Amarin has failed to persuade the US Supreme Court to consider reviving six patents on the heart medicine Vascepa (icosapent ethyl), allowing generic drugmakers Hikma Pharmaceuticals and Dr. Reddy’s Laboratories to roll out copycat products.


Amarin, Vascepa, SCOTUS, Hikma, Dr. Reddys

LSIPR